Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis

Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ecancermedicalscience
Main Authors: van Amerongen, Rosa A, Retèl, Valesca P, Coupé, Veerle MH, Nederlof, Petra M, Vogel, Maartje J, van Harten, Wim H
Format: Artigo
Jezik:Inglês
Izdano: Cancer Intelligence 2016
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5102690/
https://ncbi.nlm.nih.gov/pubmed/27899957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.684
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki